and his war cabinet this morning. the us, along with the arab states, is pushing for a further two day extension, the question is, how much leverage do they have. the united states certainly has the ability to have leverage over israel they have yet to exercise that, and that is why we are just now seeing very loud cries within us domestic policies spaces for restrictions on us aid to israel. as i m sure you are aware, in the past, we have never placed restrictions on aid to israel and therefore, we have tied our own hands and not been able to exercise leverage. it is an extremely fragile truce. three people were killed injerusalem this morning, after two gunmen opened fire at a bus stop during rush hour. hamas said the attackers who were shot then dead by police were its members. it comes a day after two palestinian boys, eight and 14, were shot and killed during an israeli army raid in the occupied west bank city ofjenin. the upsurge in violence in the west bank and
Stock analysts at SVB Leerink initiated coverage on shares of Sagimet Biosciences (NASDAQ:SGMT – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $26.00 price target on the stock. SVB Leerink’s price target suggests a potential upside of 476.50% […]
Sagimet Biosciences (NASDAQ:SGMT – Free Report) had its price target lifted by The Goldman Sachs Group from $30.00 to $37.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, JMP Securities upped their price target on Sagimet Biosciences from $31.00 to $47.00 and […]
By Colin Kellaher Shares of Sagimet Biosciences fell more than 10% in premarket trading Friday after the clinical-stage biopharmaceutical company said it was.
Sagimet Biosciences (NASDAQ:SGMT – Free Report) had its target price lifted by JMP Securities from $31.00 to $47.00 in a research report sent to investors on Monday, Benzinga reports. JMP Securities currently has a market outperform rating on the stock. Sagimet Biosciences Stock Performance Shares of Sagimet Biosciences stock opened at $18.42 on Monday. Sagimet […]